quinolinic acid and 3-hydroxykynurenine

quinolinic acid has been researched along with 3-hydroxykynurenine in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.65)	18.7374
1990's	7 (16.28)	18.2507
2000's	10 (23.26)	29.6817
2010's	22 (51.16)	24.3611
2020's	2 (4.65)	2.80

Authors

Authors	Studies
Heyes, MP; Markey, SP; Saito, K	1
Heyes, MP; Quearry, BJ	1
Fukui, S; Rapoport, SI; Schwarcz, R; Smith, QR; Takada, Y	1
Gramsbergen, JB; Schwarcz, R; Speciale, C; Vezzani, A	1
Heyes, MP; Markey, SP; Quearry, BJ	1
Katsuki, H; Nakagami, Y; Saito, H	1
Ceresoli, G; Guidetti, P; Schwarcz, R	1
Guidetti, P; Schwarcz, R	2
Ceresoli-Borroni, G; Goodman, JH; Guidetti, P; Scharfman, HE; Schwarcz, R; Speciale, C; Varasi, M; Wu, HQ	1
Buczko, W; Malyszko, J; Mysliwiec, M; Pawlak, D; Pawlak, K	1
Carpenedo, R; Meli, E; Moroni, F; Pellegrini-Giampietro, DE; Peruginelli, F	1
Clark, CJ; Darlington, LG; Forrest, CM; Mackay, GM; Stone, TW	1
BROWN, RR; HANKES, LV	1
Bates, GP; Graham, RK; Guidetti, P; Hayden, MR; Leavitt, BR; MacDonald, ME; Schwarcz, R; Slow, EJ; Wheeler, VC; Woodman, B	1
Amori, L; Ceresoli-Borroni, G; Guidetti, P; Pellicciari, R; Schwarcz, R	1
Bertram, EH; Guidetti, P; Lehrmann, E; Löve, A; Schwarcz, R; Williamson, J	1
Bannink, M; Eggermont, AM; Fekkes, D; Hengeveld, MW; Kruit, WH; Scharpé, S; Sleijfer, S; Stoter, G; van der Holt, B; Van Gool, AR; Verkerk, R	1
Amori, L; Guidetti, P; Marinozzi, M; Pellicciari, R; Schwarcz, R; Wu, HQ	1
Bien, B; Gulaj, E; Pawlak, D; Pawlak, K	1
Melzig, MF; Wszelaki, N	1
Plangar, I; Szalardy, L; Vecsei, L	1
Buerger, K; Guillemin, GJ; Hampel, H; Schwarz, MJ; Teipel, SJ	1
Fang, Q; Harris, TH; Horning, KJ; Hunter, CA; Notarangelo, FM; Schwarcz, R; Thomas, MA; Wilson, EH	1
Bellgowan, PS; Bodurka, J; Dantzer, R; Drevets, WC; Savitz, J; Smith, CM; Teague, TK; Victor, TA; Wurfel, BE	1
Bellgowan, PS; Bodurka, J; Dantzer, R; Drevets, WC; Ford, BN; Savitz, J; Teague, TK; Victor, TA; Wurfel, BE	1
Bellgowan, PS; Meier, TB; Savitz, J; Singh, R; Teague, TK	1
Bodurka, J; Dantzer, R; Drevets, WC; Ford, BN; Meier, TB; Morris, HM; Savitz, J; Teague, TK; Victor, TA; Wurfel, BE	1
de Bie, J; Grant, R; Guest, J; Guillemin, GJ	1
Buras, A; Szulc, A; Waszkiewicz, N	1
Capi, M; Curto, M; Fazio, F; Giamberardino, MA; Lionetto, L; Martelletti, P; Negro, A; Nicoletti, F; Perugino, F; Simmaco, M	1
Bodurka, J; Dantzer, R; Drevets, WC; Savitz, J; Teague, TK; Young, KD	1
Budac, DP; Elfving, B; Eskelund, A; Sanchez, C; Wegener, G	1
Bliss, SA; Dantzer, R; Drevets, WC; Ford, BN; McMillin, JR; Morris, HM; Savitz, JB; Suzuki, H; Teague, TK; Wurfel, BE	1
Neale, SA; Salt, TE; Sathyasaikumar, KV; Schwarcz, R; Tararina, M; Weisz, F; Wu, HQ	1
Robertson, DS	1
Bryn, V; Ormstad, H; Saugstad, OD; Skjeldal, OH; Verkerk, R	1
Beggiato, S; Giorgini, F; Notarangelo, FM; Sathyasaikumar, KV; Schwarcz, R	1
Adams, S; Castellano-Gonzalez, G; Cole, NJ; Don, E; Guillemin, GJ; Jacobs, KR; Lim, CK; Lovejoy, DB	1
Baldessarini, RJ; Comparelli, A; Corigliano, V; Curto, M; Fazio, F; Ferracuti, S; Lionetto, L; Nicoletti, F; Simmaco, M	1
Böhmová, A; Horáček, J; Kodym, P; Krsek, D; Mikoška, M; Syslová, K; Tejkalová, H; Vacek, L; Vondroušová, J	1
Boeira, SP; Cattelan Souza, L; Giacomeli, R; Jesse, CR; Prigol, M; Silva, MRP; Zarzecki, MS	1
Ostapiuk, A; Urbanska, EM	1

Reviews

3 review(s) available for quinolinic acid and 3-hydroxykynurenine

Article	Year
Tryptophan metabolites and brain disorders. Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:7 Topics: AIDS Dementia Complex; Brain Diseases; Central Nervous System Diseases; Humans; Huntington Disease; Kynurenine; Quinolinic Acid; Tryptophan	2003
[Depression and inflammation in rheumatic diseases]. Postepy higieny i medycyny doswiadczalnej (Online), 2016, Mar-04, Volume: 70 Topics: Cytokines; Depression; Humans; Hypothalamo-Hypophyseal System; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenic Acid; Kynurenine; Monoamine Oxidase; Pituitary-Adrenal System; Quinolinic Acid; Rheumatic Diseases; Serotonin	2016
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:1 Topics: Alzheimer Disease; Animals; Brain; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Parkinson Disease; Quinolinic Acid; Signal Transduction	2022

Other Studies

40 other study(ies) available for quinolinic acid and 3-hydroxykynurenine

Article	Year
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience, 1992, Volume: 51, Issue:1 Topics: Animals; Antibodies, Monoclonal; Brain; Immune System; Interferon-gamma; Kynurenic Acid; Kynurenine; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Models, Biological; Pokeweed Mitogens; Quinolinic Acid; Recombinant Proteins; Tryptophan	1992
Increased L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid concentrations in cerebral cortex following systemic endotoxin administration. Advances in experimental medicine and biology, 1991, Volume: 294 Topics: Animals; Brain Chemistry; Cerebral Cortex; Endotoxins; Hydroxyindoleacetic Acid; Kynurenine; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Quinolinic Acid; Quinolinic Acids; Serotonin; Stimulation, Chemical; Tryptophan	1991
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. Journal of neurochemistry, 1991, Volume: 56, Issue:6 Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Kynurenic Acid; Kynurenine; Male; ortho-Aminobenzoates; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains	1991
Production of quinolinic acid and kynurenic acid by human glioma. Advances in experimental medicine and biology, 1991, Volume: 294 Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; 3-Hydroxyanthranilic Acid; Astrocytoma; Brain Neoplasms; Dioxygenases; Humans; Hydrolases; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neoplasm Proteins; Oxygenases; Quinolinic Acid; Quinolinic Acids	1991
Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain research, 1989, Jul-03, Volume: 491, Issue:1 Topics: Animals; Cerebral Cortex; Endotoxins; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Kynurenine; Mice; Mice, Inbred C57BL; Pyridines; Quinolinic Acid; Quinolinic Acids; Salmonella; Time Factors; Tryptophan	1989
3-Hydroxykynurenine toxicity on the rat striatum in vivo. Japanese journal of pharmacology, 1996, Volume: 71, Issue:2 Topics: Acetylcysteine; Animals; Brain Diseases; Corpus Striatum; Free Radical Scavengers; Injections, Intraventricular; Kynurenine; Male; Quinolinic Acid; Rats; Rats, Wistar	1996
Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections. Brain research. Developmental brain research, 1997, May-20, Volume: 100, Issue:1 Topics: Aging; Animals; Brain; Corpus Striatum; Functional Laterality; Glutamate Decarboxylase; Ibotenic Acid; Kynurenine; Male; Microinjections; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Time Factors; Tritium; Xanthurenates	1997
3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. The European journal of neuroscience, 1999, Volume: 11, Issue:11 Topics: 2-Amino-5-phosphonovalerate; Afferent Pathways; Animals; Benzenesulfonates; Corpus Striatum; Drug Synergism; Electron Transport Complex IV; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Kynurenine; Male; Motor Activity; N-Methylaspartate; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase	1999
Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. Neuroscience, 2000, Volume: 97, Issue:2 Topics: 3-Hydroxyanthranilic Acid; Animals; Blood-Brain Barrier; Butyrates; Enzyme Inhibitors; Hippocampus; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Mixed Function Oxygenases; Neuroprotective Agents; Neurotoxins; Pyramidal Cells; Quinolinic Acid; Rats; Rats, Sprague-Dawley	2000
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. International urology and nephrology, 2001, Volume: 33, Issue:2 Topics: Female; Humans; Kidney; Kynurenic Acid; Kynurenine; Male; Middle Aged; ortho-Aminobenzoates; Quinolinic Acid; Renal Dialysis; Tryptophan; Uremia; Xanthurenates	2001
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. Journal of neurochemistry, 2002, Volume: 82, Issue:6 Topics: Alanine; Animals; Brain Ischemia; Cell Death; Cell Hypoxia; Culture Media, Conditioned; Enzyme Inhibitors; Glucose; Hippocampus; In Vitro Techniques; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neurons; Neuroprotective Agents; Pyramidal Cells; Quinolinic Acid; Rats; Sulfonamides; Thiazoles	2002
3-Hydroxykynurenine-keto-C14: a precursor of urinary quinolinic acid. Biochemical and biophysical research communications, 1961, Jan-25, Volume: 4 Topics: Body Fluids; Humans; Kynurenine; Pyridines; Quinolinic Acid	1961
3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Advances in experimental medicine and biology, 2003, Volume: 527 Topics: Aged; Animals; Butyrates; Case-Control Studies; Cerebellum; Corpus Striatum; Frontal Lobe; Humans; Huntington Disease; Kynurenine; Male; Middle Aged; Models, Neurological; Neostriatum; Quinolinic Acid; Rats; Rats, Sprague-Dawley	2003
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiology of disease, 2006, Volume: 23, Issue:1 Topics: Age Factors; Animals; Brain Chemistry; Chromatography, Gas; Chromatography, High Pressure Liquid; Disease Models, Animal; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Mice; Mice, Transgenic; Quinolinic Acid	2006
Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications. Journal of neuroscience research, 2007, Volume: 85, Issue:4 Topics: Animals; Animals, Newborn; Brain Chemistry; Cyclopropanes; Deoxycholic Acid; Drug Administration Schedule; Embryo, Mammalian; Enzyme Inhibitors; Female; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Liver; Metabolic Networks and Pathways; Mice; Parturition; Pregnancy; Prenatal Exposure Delayed Effects; Quinolinic Acid; Rats; Rats, Sprague-Dawley	2007
Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice. Epilepsia, 2008, Volume: 49 Suppl 2 Topics: Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Cell Count; Coloring Agents; Cricetinae; Disease Models, Animal; Electroencephalography; Encephalitis, Viral; Hippocampus; Kynurenine; Measles virus; Mice; Mice, Inbred BALB C; Microglia; Monitoring, Physiologic; Nerve Degeneration; Neuroglia; Pyramidal Cells; Quinolinic Acid; Seizures; Tryptophan	2008
Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5 Topics: Adult; Aged; Brain; Carcinoma, Renal Cell; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunologic Factors; Injections, Subcutaneous; Interferon-alpha; Kidney Neoplasms; Kynurenine; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Neurotoxins; Quinolinic Acid	2008
Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience, 2009, Mar-03, Volume: 159, Issue:1 Topics: Adenosine; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Fluid; Functional Laterality; Kynurenic Acid; Kynurenine; Mice; Mice, Knockout; Microdialysis; Nerve Degeneration; Norbornanes; Quinolinic Acid; Transaminases; Tritium	2009
Kynurenine and its metabolites in Alzheimer's disease patients. Advances in medical sciences, 2010, Volume: 55, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Chromatography, High Pressure Liquid; Female; Humans; Kynurenic Acid; Kynurenine; Male; ortho-Aminobenzoates; Quinolinic Acid; Tryptophan	2010
Research on an in vitro cell system for testing the neurotoxicity of kynurenine pathway metabolites. Die Pharmazie, 2011, Volume: 66, Issue:11 Topics: Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Coloring Agents; Fluorescent Antibody Technique; Humans; Hydroxydopamines; Isoquinolines; Kynurenine; Neuroblastoma; Neurotoxins; Quinolinic Acid; Tetrazolium Salts; Thiazoles; Tretinoin	2011
Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases? Expert review of clinical pharmacology, 2012, Volume: 5, Issue:4 Topics: Animals; Drug Design; Humans; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Quinolinic Acid	2012
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls. European archives of psychiatry and clinical neuroscience, 2013, Volume: 263, Issue:4 Topics: Aged; Alzheimer Disease; Biomarkers; Blood-Brain Barrier; Brain Chemistry; Chromatography, High Pressure Liquid; Cognition Disorders; Female; Gas Chromatography-Mass Spectrometry; Humans; Kynurenic Acid; Kynurenine; Male; Neuropsychological Tests; Picolinic Acids; Quinolinic Acid; Spectrophotometry, Ultraviolet; Tryptophan	2013
Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. Schizophrenia research, 2014, Volume: 152, Issue:1 Topics: Animals; Anti-Infective Agents; Brain; Disease Models, Animal; Drug Combinations; Female; Kynurenic Acid; Kynurenine; Mice; Mice, Inbred C57BL; Neuroglia; Pyrimethamine; Quinolinic Acid; RNA, Messenger; Signal Transduction; Sulfadiazine; Time Factors; Toxoplasmosis; Tryptophan	2014
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:2 Topics: Adult; Amygdala; Anhedonia; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Depressive Disorder, Major; Female; Gray Matter; Hippocampus; Humans; Kynurenic Acid; Kynurenine; Male; Organ Size; Psychiatric Status Rating Scales; Quinolinic Acid; Receptors, Interleukin-1; Signal Transduction; Tryptophan	2015
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology, 2015, Volume: 52 Topics: Adult; Amygdala; Bipolar Disorder; Female; Hippocampus; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Quinolinic Acid	2015
Smaller Dentate Gyrus and CA2 and CA3 Volumes Are Associated with Kynurenine Metabolites in Collegiate Football Athletes. Journal of neurotrauma, 2016, 07-15, Volume: 33, Issue:14 Topics: Adolescent; Adult; Athletes; Athletic Injuries; Brain Concussion; CA2 Region, Hippocampal; CA3 Region, Hippocampal; Dentate Gyrus; Football; Humans; Kynurenine; Magnetic Resonance Imaging; Male; Quinolinic Acid; Universities; Young Adult	2016
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain, behavior, and immunity, 2016, Volume: 53 Topics: Adult; Brain; C-Reactive Protein; Case-Control Studies; Cerebral Cortex; Depressive Disorder, Major; Female; Gray Matter; Humans; Kynurenic Acid; Kynurenine; Magnetic Resonance Imaging; Male; Neurotoxicity Syndromes; Prefrontal Cortex; Quinolinic Acid; Tryptophan	2016
Central kynurenine pathway shift with age in women. Journal of neurochemistry, 2016, Volume: 136, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aging; Brain; Female; Humans; Inflammation; Kynurenic Acid; Kynurenine; Middle Aged; Neopterin; Neurotoxins; Quinolinic Acid; Tryptophan; Tryptophan Oxygenase; Young Adult	2016
Altered serum levels of kynurenine metabolites in patients affected by cluster headache. The journal of headache and pain, 2015, Volume: 17 Topics: Adult; Cluster Headache; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Male; Middle Aged; ortho-Aminobenzoates; Quinolinic Acid; Tryptophan; Xanthurenates	2015
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain, behavior, and immunity, 2016, Volume: 56 Topics: Adult; Depressive Disorder, Major; Female; Hippocampus; Humans; Kynurenic Acid; Kynurenine; Magnetic Resonance Imaging; Male; Memory, Episodic; Mental Recall; Middle Aged; Quinolinic Acid; Young Adult	2016
Female Flinders Sensitive Line rats show estrous cycle-independent depression-like behavior and altered tryptophan metabolism. Neuroscience, 2016, 08-04, Volume: 329 Topics: 5-Hydroxytryptophan; Animals; Anxiety; Brain; Depressive Disorder; Disease Models, Animal; Estrous Cycle; Female; Kynurenine; Male; Motor Activity; ortho-Aminobenzoates; Quinolinic Acid; Rats; Resilience, Psychological; Sex Characteristics; Tryptophan	2016
Serum kynurenic acid is reduced in affective psychosis. Translational psychiatry, 2017, 05-02, Volume: 7, Issue:5 Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Corpus Striatum; Cytokines; Depression; Depressive Disorder, Major; Female; GABAergic Neurons; Humans; Inflammation; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Middle Aged; Psychotic Disorders; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate; Schizophrenia	2017
Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects. Neuroscience, 2017, Dec-26, Volume: 367 Topics: Aged; Animals; Brain; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fluoroquinolones; Glucose; Glutamine; Humans; In Vitro Techniques; Kynurenine; Male; Mice; Middle Aged; Piperazines; Postmortem Changes; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tacrolimus; Temperature; Tissue Distribution; Transaminases; Veratridine; Xanthurenates	2017
Proposed biochemistry of Parkinson's and Alzheimer's diseases. Medical hypotheses, 2017, Volume: 109 Topics: Aldehydes; Alzheimer Disease; Aspartic Acid; Betaine; Brain; Disease Progression; Humans; Kynurenine; Lewy Bodies; Models, Biological; Parkinson Disease; Plaque, Amyloid; Pyruvaldehyde; Quinolinic Acid; Treatment Outcome	2017
Kynurenine Pathway in Autism Spectrum Disorders in Children. Neuropsychobiology, 2017, Volume: 76, Issue:2 Topics: Autism Spectrum Disorder; Biomarkers; Child; Chromatography, High Pressure Liquid; Comorbidity; Female; Humans; Kynurenic Acid; Kynurenine; Male; Quinolinic Acid; Tryptophan	2017
Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia. Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:11 Topics: Animals; Brain; Cognitive Dysfunction; Female; Genotype; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mice; Mice, Inbred C57BL; Mice, Knockout; Placenta; Pregnancy; Quinolinic Acid; Schizophrenia	2018
Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms. Neurotoxicity research, 2019, Volume: 35, Issue:3 Topics: Adenosine Triphosphate; Brain; Cell Survival; HEK293 Cells; Humans; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; NAD; Neurons; Oxidative Stress; Primary Cell Culture; Quinolinic Acid; Reactive Oxygen Species	2019
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis. Schizophrenia research, 2019, Volume: 208 Topics: Adolescent; Adult; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Male; ortho-Aminobenzoates; Prodromal Symptoms; Psychotic Disorders; Quinolinic Acid; Risk; Schizophrenia; Tryptophan; Xanthurenates; Young Adult	2019
Monitoring of kynurenine pathway metabolites, neurotransmitters and their metabolites in blood plasma and brain tissue of individuals with latent toxoplasmosis. Journal of pharmaceutical and biomedical analysis, 2019, Jun-05, Volume: 170 Topics: Animals; Brain; Chromatography, High Pressure Liquid; Hydroxyindoleacetic Acid; Kynurenine; Male; Neurotransmitter Agents; Plasma; Quinolinic Acid; Rats; Rats, Wistar; Serotonin; Tandem Mass Spectrometry; Toxoplasmosis; Tryptophan	2019
Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice. Neurochemical research, 2020, Volume: 45, Issue:12 Topics: Animals; Body Weight; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Gene Expression; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenine; Kynurenine 3-Monooxygenase; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Oximes; Peptide Fragments; Quinolinic Acid; Sulfonamides; Tryptophan	2020